Nadide

Especificaciones

53-84-9Número CAS

200-184-4Número CE

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphateNombre IUPAC

C21H27N7O14P2Fórmula química

663.4 g/molPeso molecular

nadide; 53-84-9; coenzyme I; beta-NAD; Codehydrogenase I; Codehydrase I; nicotinamide adenine dinucleotide; diphosphopyridine nucleotide; Cozymase I; beta-Diphosphopyridine nucleotide; Enzopride; COZYMASE; Nadidum; Nicotinamide-adenine dinucleotide; codehydrogenase; Nadida; Pyridine, nucleotide diphosphate; Adenine-nicotinamide dinucleotide; Nicotineamide adenine dinucleotide; Nadidum [INN-Latin]; Nadida [INN-Spanish]; .beta.-NAD; Nadide [USAN:INN:BAN:JAN]; EINECS 200-184-4; NSC 20272; BRN 3584133; 0U46U6E8UK; NADIDE [USAN]; NADIDUM [HPUS]; NADIDE [INN]; NADIDE [JAN]; NADIDE [WHO-DD]; NADIDE [MART.]; NSC-20272; NAD(SUP +); 3-Carbamoyl-1-beta-D-ribofuranosylpyridinium hydroxide, 5'-ester with adenosine 5'-pyrophosphate, inner salt; Nicotinamide Adinine Dinucleotide; EC 200-184-4; 5-26-16-00399 (Beilstein Handbook Reference); Adenosine 5'-(trihydrogen diphosphate), P'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium hydroxide, inner salt; Nadidum (INN-Latin); Nadida (INN-Spanish); NADIDE (MART.); Adenosine 5'-(trihydrogen diphosphate), 5'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, hydroxide, inner salt; Pyridinium, 3-carbamoyl-1-beta-D-ribofuranosyl-, hydroxide, 5'-ester with adenosine 5'-5'-(trihydrogen pyrophosphate), inner salt; betaNAD+; 3-CARBAMOYL-1-.BETA.-D-RIBOFURANOSYLPYRIDINIUM HYDROXIDE 5'->5'-ESTER WITH ADENOSINE 5'-(TRIHYDROGEN PYROPHOSPHATE) INNER SALT; 3-CARBAMOYL-1-.BETA.-D-RIBOFURANOSYLPYRIDINIUM HYDROXIDE, 5'-ESTER WITH ADENOSINE 5'-PYROPHOSPHATE, INNER SALT; ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE) P'->5'-ESTER WITH 3-(AMINOCARBONYL)-1-.BETA.-D-RIBOFURANOSYLPYRIDINIUM INNER SALT; ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE), 5'->5'-ESTER WITH 3-(AMINOCARBONYL)-1-.BETA.-D-RIBOFURANOSYLPYRIDINIUM, HYDROXIDE, INNER SALT; Adenosine 5'-(trihydrogen diphosphate), P'->5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt; Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt; nadid; betaNAD; (((2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy-oxidophosphoryl) ((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl)methyl phosphate;hydron; ((2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)methyl (((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl)methoxy-hydroxyphosphoryl) phosphate; [(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphate; [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate;hydron; Viatrexx-NAD Plus; (((2R,3S,4R,5R)-5-(6-amino-7H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy-oxidophosphoryl) ((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl)methyl phosphate; [[(2R,3S,4R,5R)-5-(6-amino-7H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate; RefChem:831676; Adenosine 5'-(trihydrogen diphosphate), P'.fwdarw.5'-ester with 3-(aminocarbonyl)-1-.beta.-D-ribofuranosylpyridinium, inner salt; Adeninenicotinamide dinucleotide; betaDiphosphopyridine nucleotide; Nicotinamideadenine dinucleotide; betaNicotinamide adenine dinucleotide; NICOTINAMIDE ADENINE DINUCLEOTIDE [INCI]; 200-184-4; 3-CARBAMOYL-1-BETA-D-RIBOFURANOSYLPYRIDINIUM HYDROXIDE 5'->5'-ESTER WITH ADENOSINE 5'-(TRIHYDROGEN PYROPHOSPHATE) INNER SALT; 3-Carbamoyl-1-Beta-D-Ribofuranosylpyridinium Hydroxide 5'-5'-Ester with Adenosine 5'-(Trihydrogen Pyrophosphate) Inner Salt; 3Carbamoyl1betaDribofuranosylpyridinium hydroxide, 5'ester with adenosine 5'pyrophosphate, inner salt; Adenosine 5'(trihydrogen diphosphate), 5'5'ester with 3(aminocarbonyl)1betaDribofuranosylpyridinium, hydroxide, inner salt; Adenosine 5'(trihydrogen diphosphate), P'.fwdarw.5'ester with 3(aminocarbonyl)1betaDribofuranosylpyridinium, inner salt; Adenosine 5'(trihydrogen diphosphate), P'>5'ester with 3(aminocarbonyl)1betaDribofuranosylpyridinium, inner salt; Adenosine 5'(trihydrogen diphosphate), P'5'ester with 3(aminocarbonyl)1betaDribofuranosylpyridinium hydroxide, inner salt; Adenosine 5'(trihydrogen diphosphate), P'5'ester with 3(aminocarbonyl)1betaDribofuranosylpyridinium, inner salt; ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE) P'->5'-ESTER WITH 3-(AMINOCARBONYL)-1-BETA-D-RIBOFURANOSYLPYRIDINIUM INNER SALT; ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE), 5'->5'-ESTER WITH 3-(AMINOCARBONYL)-1-BETA-D-RIBOFURANOSYLPYRIDINIUM, HYDROXIDE, INNER SALT; Pyridinium, 3carbamoyl1betaDribofuranosyl, hydroxide, 5'ester with adenosine 5'5'(trihydrogen pyrophosphate), inner salt; (((2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy-hydroxyphosphoryl) ((2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl)methyl hydrogen phosphate; [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate; NAD+; beta-nicotinamide adenine dinucleotide; beta-NAD+; NAD; CO-I; NAD Lithium salt; Nicotinamide dinucleotide; NAD zwitterion; CO-1; beta-DPN; DTXSID2045236; Coenzyme 1; MFCD00036253; 1-((2R,3R,4S,5R)-5-((((((((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)oxy)oxidophosphoryl)oxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-3-carbamoylpyridin-1-ium; 64417-72-7; Nicotinamide adenine dinucleotide (NAD); DPN-ox; Endopride; DPN+; beta-Nicotinamide adenine dinucleotide hydrate; beta-Nicotinamide adenine dinucleotide(NAD); beta-Diphosphopyridinenucleotide; Co I; Adenosine 5'-(trihydrogen diphosphate), P'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt; UNII-0U46U6E8UK; NADLithiumsalt; NSC20272; NAD trihydrate; CAS-53-84-9; NCGC00016240-01; NAD+ (Standard); [adenylate-32-P]-NAD; Carbonyl [14C] NAD+; NAD [MI]; NAD, Grade I, free acid; ?-NAD; [adenylate-32-P]-NAD+; NAD, Grade II, free acid; SCHEMBL131544; SPECTRUM1500419; Pyridine nucleotide diphosphate; GTPL2451; CHEMBL1234613; DTXCID0025236; SCHEMBL29351635; SCHEMBL29353727; CHEBI:44215; HMS500J11; HY-B0445R; [14C] NAD+; [32P] NAD+; BDBM213227; GLXC-10877; HMS2091H06; HMS2097E04; HMS3714E04; Pharmakon1600-01500419; EX-A3535; HY-B0445; Tox21_110321; CCG-40114; MSK000609; NSC757121; s2518; bera-Nicotinamide adenine dinucleotide; AKOS015892319; beta-nicotinamide adenine din-ucleotide; DB14128; EBC-616214; NN11969; NSC-757121; .beta.-Nicotinamide adenine dinucleotide; NCGC00178839-01; NCGC00178839-02; NCGC00178839-03; NCGC00178839-08; [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate; |A-DPN; |A-NAD; Coenzyme 1; Nadide; 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1lambda5-pyridin-1-ylium; AC-37031; AS-14652; BP-58726; SBI-0051451.P003; |A-Nicotinamide Adenine Dinucleotide Hydrate; AB00513910; D0919; NS00100300; -DPN;-NAD;-Nicotinamide Adenine Dinucleotide; A11563; beta-Nicotinamide adenine dinucleotide, reduced; AB00052048_03; beta-Nicotinamide adenine dinucleotide trihydrate; beta-Nicotinamide adenine dinucleotide hydrate, >=99%; Q12499775; |A-Nicotinamide adenine dinucleotide pound NAD pound(c); F45C0D6C-DA87-47BE-9975-7A5DE9CCB985; beta-Nicotinamide adenine dinucleotide hydrate, >=95% (HPLC); beta-Nicotinamide adenine dinucleotide, pkg of 10 mg (per vial); beta-Nicotinamide adenine dinucleotide, pkg of 20 mg (per vial); beta-Nicotinamide adenine dinucleotide, pkg of 50 mg (per vial); beta-Nicotinamide adenine dinucleotide hydrate, >=98%, BioUltra, from yeast; beta-Nicotinamide adenine dinucleotide hydrate, Grade AA-1, >=95% (HPLC); 3-Carbamoyl-1-D-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate; beta-Nicotinamide adenine dinucleotide hydrate, purified by column chromatography, >=99%; beta-Nicotinamide adenine dinucleotide hydrate, Vetec(TM) reagent grade, >=96.5%; [(3S,2R,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(3S,2R,4R,5R)-5-(3-carbamoylpyridyl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxyphosphoryl) hydrogen phosphate; [(3S,2R,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl {[(3S,2R,4R,5R)-5-(3-carbamoylpyridyl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxyphosphoryl)hydrogen phosphate; [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate; 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1-pyridin-1-ylium; 3-Carbamoyl-1-beta-D-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate inner salt; 3-Carbamoyl-1-beta-delta-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate inner salt; 3-Carbamoyl-1-delta-ribofuranosylpyridinium hydroxide 5'-ester with adenosine 5'-pyrophosphate; Adenosine 5'-(trihydrogen diphosphate-P-32P), P'>5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt (9CI); beta-Nicotinamide adenine dinucleotide hydrate, >=96.5% (HPLC), >=96.5% (spectrophotometric assay), from yeast; beta-Nicotinamide adenine dinucleotide hydrate, cell culture tested, >=96.5% (HPLC), >=96.5% (spectrophotometric assay), from yeast; Pyridinium, 3-carbamoyl-1-b-D-ribofuranosyl-, hydroxide, 5'-5'-ester with adenosine 5'-(trihydrogen pyrophosphate), inner salt (8CI)Sinónimos